Gilead’s Captisol-enabled Remdesivir Approved for Use in Renally Impaired Patients
Read full release and find prescribing information
Gilead’s Captisol-enabled Remdesivir Approved for Use in Renally Impaired Patients
Read full release and find prescribing information
Captisol® is supplied in 20g, 100g, 500g, 1 Kg, 5 Kg and 20 Kg packages for research and development use.
Captisol® is available in commercial quantities. Standard configurations are 500 g, 1 Kg, 5 Kg and 20 Kg.
Non-clinical and clinical material are chemically identical, however non-clinical material may have slightly different physical characteristics (dissolves slower under certain conditions, smaller particle size, less flowable), have been repackaged in general laboratory conditions, and/or may lack full documentation regarding validation of the process.
View our easy-to-use PDF for more information on how to use Captisol®
Contact us today and take the first step to a great partnership.